VIT Vitura Health Ltd
- 0.094
- +0.006+6.82%
Vitura Health Ltd News
Could The Market Be Wrong About Vitura Health Limited (ASX:VIT) Given Its Attractive Financial Prospects?
Vitura Health Resets Business Strategy
Vitura Health (ASX:VIT) on Wednesday launched its business strategy reset following a strategic review conducted by recently appointed Chairman Robert Iervasi, according to a same-day filing with the
Vitura Health's Shares Jump 19% After Securing Injunction Order Over Code4 Spat
Vitura Health's (ASX:VIT) shares jumped 19% on Friday after its subsidiary, Canview, secured an injunction order restraining Code4 Cannabis from terminating their services agreement. The Supreme Court
Vitura Health's Services Agreement With Code4 at Risk of Termination; Shares Plunge 31%
Vitura Health (ASX:VIT) is taking Code4 Cannabis to court amid a looming termination of an agreement between the two companies, sending the ASX-listed company's shares down more than 30% at Tuesday's
Vitura Health CEO to Step Down by June-End
Rodney Cocks will step down as CEO and executive director of digital health platform Vitura Health (ASX:VIT), effective June 30, according to a Monday filing with the Australian Securities Exchange. T
Vitura Health JV Commences Manufacture of GMP LaNeo MDMA; Shares Up 3%
Vitura Health (ASX:VIT), through its joint venture, Cortexa, commenced manufacturing of GMP LaNeo MDMA 40mg capsules to support both clinical trials and use under the Therapeutic Goods Administration'
Vitura Health Joint Venture Supplies First Psilocybin for Patient Use Outside Trial
Vitura Health (ASX:VIT) joint venture Cortexa has supplied GMP psilocybin for therapeutic use by a patient outside a clinical trial, according to an Australian bourse announcement on Monday. Cortexa i
Vitura Health Appoints Independent Chair
Vitura Health (ASX:VIT) appointed Robert Iervasi as independent chair to succeed Marcia Walker, who has been serving as interim chair since September 2023. Iervasi serves as chair at Luv-a-Duck and Ch
Vitura Health Integrates Nicotine Vaping Products Into Prescription Platform
Vitura Health (ASX:VIT) integrated prescription-only nicotine vaping products (NPVs) into its prescription platform CanView, the digital health firm said on Tuesday. The company included smoking cessa
Australian Shares Rally Following Christmas Holiday
Australian shares rose Wednesday amid broad-based gains as the market reopened following the Christmas holidays. The S&P/ASX 200 Index rose 59.60 points, or 0.8%, to 7,561.20. The gains were led by th
Vitura Health Services' Canview Services Deal to Not Be Extended; Shares Plunge 20%
Vitura Health (ASX:VIT) said Wednesday that Code4 Cannabis (C4C) does not intend to extend its services agreement with company subsidiary Canview after Vitura raised a number of issues related to C4C'
Vitura Health's CanView Platform Achieves 2 Millionth Sale of Medicinal Cannabis
Vitura Health (ASX:VIT) sold the 2 millionth unit of medicinal cannabis through the CanView platform. The CanView platform was launched in June 2020 and hit its 1 millionth milestone in December 2022,
The Compensation For Vitura Health Limited's (ASX:VIT) CEO Looks Deserved And Here's Why
Is Weakness In Vitura Health Limited (ASX:VIT) Stock A Sign That The Market Could Be Wrong Given Its Strong Financial Prospects?
Vitura Health Signs Agreement to Acquire Doctors on Demand; Shares Jump 6%
Vitura Health (ASX:VIT) entered into a binding agreement to acquire the entire issued capital of Doctors on Demand for AU$25 million, which comprises an upfront cash component, a deferred cash compone
Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching
A Look At The Fair Value Of Vitura Health Limited (ASX:VIT)
Vitura Health Price Target Cut 22% to A$0.70/Share by Bell Potter
Vitura Health Price Target Cut 22% to A$0.70/Share by Bell Potter
Vitura Health Secures WHO GDP Certification for Gold Coast and Melbourne Distribution Centers
Australian medicinal cannabis company Vitura Health (ASX:VIT) said Wednesday that its Gold Coast and Melbourne distribution centers secured the 'Good Distribution Practices' certification from the Wor
Vitura Health (ASX:VIT) Delivers Shareholders Incredible 60% CAGR Over 3 Years, Surging 12% in the Last Week Alone
Analysis
Price Target
No Data
